“Nearly two years after Google DeepMind released an updated AlphaFold3 geared at drug discovery, its biopharmaceuticals spin-off, Isomorphic Labs, announced an even more powerful artificial-intelligence model…

Isomorphic Labs, based in London, touted the capacities of its ‘drug-discovery engine’ — which it calls IsoDDE — in a 27-page technical report, released on 10 February. Achievements, including precise predictions of how proteins interact with potential drugs and antibody structures, have impressed scientists working in the field.”

From Nature.